Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00161577 · ClinicalTrials.gov registry record · Phase 4
Use of Ketorolac in Management of Post-Operative Pain After Heart Surgery
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- Phase 4
- Development phase
- 25
- Enrollment target
NCT00161577 is a Phase 4 study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 25 participants.
The verdict
NCT00161577, a Phase 4 study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study evaluates the safety and efficacy of ketorolac for post-operative pain management after heart surgery. Ketorolac appears to provide enhanced pain relief while also decreasing the requirements for morphine during the (immediate) 24-hour post-operative period.
Interventions
- OTHER Placebo
- DRUG Ketorolac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2004-01 |
| Est. Completion | 2006-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00161577
The ClinicalTrials.gov registry entry for NCT00161577 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00161577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00161577 about?
NCT00161577 is a clinical study titled "Use of Ketorolac in Management of Post-Operative Pain After Heart Surgery". This study evaluates the safety and efficacy of ketorolac for post-operative pain management after heart surgery. Ketorolac appears to provide enhanced pain relief while also decreasing the requirements for morphine during the (immediate) 24-hour post-operative period.
What is the current status of trial NCT00161577?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 25 participants. The study started on 2004-01. Estimated completion is 2006-06.
What interventions are being tested in trial NCT00161577?
The interventions under investigation include: Placebo (OTHER), Ketorolac (DRUG).
Who is sponsoring clinical trial NCT00161577?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.